受强制性开放获取政策约束的文章 - Jaspreet Singh Batra, MD了解详情
可在其他位置公开访问的文章：5 篇
Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic …
ST Tagawa, S Vallabhajosula, PJ Christos, YS Jhanwar, JS Batra, L Lam, ...
Cancer 125 (15), 2561-2569, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate …
JS Batra, MJ Niaz, YE Whang, A Sheikh, C Thomas, P Christos, ...
Urologic Oncology: Seminars and Original Investigations 38 (11), 848. e9-848 …, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (177Lu‐J591) for Metastatic …
MJ Niaz, JS Batra, RD Walsh, MK Ramirez‐Fort, S Vallabhajosula, ...
The oncologist 25 (6), 477-e895, 2020
强制性开放获取政策： US National Institutes of Health
Formalizing an integrative, multidisciplinary cancer therapy discovery workflow
MF McGuire, H Enderling, DI Wallace, J Batra, M Jordan, S Kumar, ...
Cancer research 73 (20), 6111-6117, 2013
强制性开放获取政策： US National Institutes of Health
A quest to identify prostate cancer circulating biomarkers with a bench‐to‐bedside potential
JS Batra, S Girdhani, L Hlatky
Journal of biomarkers 2014 (1), 321680, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定